Verisim Life secures $15M series A funding

By The Science Advisory Board staff writers

January 10, 2022 -- Verisim Life announced it has closed an oversubscribed $15 million series A financing round. Proceeds will help Verisim scale its operations, democratize its virtual drug development engine Bioisim, fast-track its sales and marketing efforts, and continue establishing partnerships with industry and academia, the company said.

The Bioisim platform, which is driven by artificial intelligence (AI) and machine learning (ML), de-risks R&D decisions by providing meaningful insights earlier in the drug development process with unprecedented accuracy and scalability, said Verisim.

The financing was led by Morpheus Ventures. Additional new investors include Debiopharm Innovation Fund and Colorcon Ventures, with continued support from existing investors OCA Ventures, Intel Capital, Serra Ventures, and Susa Ventures.

20n Bio raises $3.3M to advance computational design of protein therapeutics
20n Bio (20n), an artificial intelligence (AI)-powered drug discovery company focused on designing new proteins for therapeutics, has raised a $3.3 million...
Akoya Biosciences, PathAI collaborate on novel predictive biomarkers
Akoya Biosciences is collaborating with PathAI to advance the discovery and validation of novel predictive biomarkers for immunotherapies. The collaboration...
Metis Therapeutics launches with $86M to redefine drug discovery
Metis Therapeutics has launched with $86 million in series A financing to harness artificial intelligence and machine learning to redefine drug discovery...

Copyright © 2022 scienceboard.net


Conferences
International Society for Cell and Gene Therapy Annual Meeting
May 4 - June 7
San Francisco, California United States
Interphex 2022 Conference
May 24-26
New York, New York United States
American Society for Mass Spectrometry Annual Conference
June 5-9
Minneapolis, Minnesota United States
American Society for Microbiology Microbe Meeting
June 9-13
District of Columbia United States
HPLC 2022
June 18-23
San Diego, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter